Intelligent packaging can cut cost of trials; Stora Enso

By Nick Taylor

- Last updated on GMT

Related tags: Pharmacology

Using intelligent compliance packaging in clinical trials can result in “huge cost savings” and this will ensure demand even during a period of cost-cutting, according to a sales manager at Stora Enso.

Sari Hakili, sales manager, pharmaceutical solutions at Stora Enso Carton Board, explained that the cost of non-compliance makes intelligent packaging economically viable.

Intelligent packaging can reduce the workload on nurses and automate some processes, including data entry, leading to cost-savings, according to Hakli. Furthermore, as with all electronics, the cost will come down as the packaging is produced in larger volumes.

Hakli added that the packaging can be customised. These modifications can remind patients they have forgotten to take a tablet or alert them if they take their midday medication in the evening.

Related topics: Drug Delivery, Processing equipment

Related news

Related products

The battle of performance in pharma production

The battle of performance in pharma production

Telstar Life Science Solutions | 26-Mar-2019 | Case Study

Telstar case study. Discover how a versatile freeze-dryer automatic loading & unloading systemDiscover how a versatile freeze-dryer automatic loading...

Accelerate your supply chain as pressures intensify

Accelerate your supply chain as pressures intensify

William Reed | 17-Sep-2018 | Technical / White Paper

Food, Drink and Non-Food manufacturers are under pressure. Range reviews, massive retail mergers, the backlash against plastic packaging and the ongoing...


Optimizing vessel geometry for mag drive agitators

Steridose, Inc | 14-Sep-2017 | Technical / White Paper

The performance of a bottom mount magnetically driven agitator (mag drive mixer) is heavily dependent on its relationship with the vessel’s geometry, baffles,...

Related suppliers